235 related articles for article (PubMed ID: 27420797)
1. Enhancing dengue virus maturation using a stable furin over-expressing cell line.
Mukherjee S; Sirohi D; Dowd KA; Chen Z; Diamond MS; Kuhn RJ; Pierson TC
Virology; 2016 Oct; 497():33-40. PubMed ID: 27420797
[TBL] [Abstract][Full Text] [Related]
2. Mechanism and significance of cell type-dependent neutralization of flaviviruses.
Mukherjee S; Dowd KA; Manhart CJ; Ledgerwood JE; Durbin AP; Whitehead SS; Pierson TC
J Virol; 2014 Jul; 88(13):7210-20. PubMed ID: 24741083
[TBL] [Abstract][Full Text] [Related]
3. Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2.
da Silva Voorham JM; Rodenhuis-Zybert IA; Ayala Nuñez NV; Colpitts TM; van der Ende-Metselaar H; Fikrig E; Diamond MS; Wilschut J; Smit JM
PLoS One; 2012; 7(3):e29957. PubMed ID: 22431958
[TBL] [Abstract][Full Text] [Related]
4. Differential modulation of prM cleavage, extracellular particle distribution, and virus infectivity by conserved residues at nonfurin consensus positions of the dengue virus pr-M junction.
Junjhon J; Lausumpao M; Supasa S; Noisakran S; Songjaeng A; Saraithong P; Chaichoun K; Utaipat U; Keelapang P; Kanjanahaluethai A; Puttikhunt C; Kasinrerk W; Malasit P; Sittisombut N
J Virol; 2008 Nov; 82(21):10776-91. PubMed ID: 18715923
[TBL] [Abstract][Full Text] [Related]
5. Combined effects of the structural heterogeneity and dynamics of flaviviruses on antibody recognition.
Dowd KA; Mukherjee S; Kuhn RJ; Pierson TC
J Virol; 2014 Oct; 88(20):11726-37. PubMed ID: 25078693
[TBL] [Abstract][Full Text] [Related]
6. Functional importance of dengue virus maturation: infectious properties of immature virions.
Zybert IA; van der Ende-Metselaar H; Wilschut J; Smit JM
J Gen Virol; 2008 Dec; 89(Pt 12):3047-3051. PubMed ID: 19008392
[TBL] [Abstract][Full Text] [Related]
7. A fusion-loop antibody enhances the infectious properties of immature flavivirus particles.
Rodenhuis-Zybert IA; Moesker B; da Silva Voorham JM; van der Ende-Metselaar H; Diamond MS; Wilschut J; Smit JM
J Virol; 2011 Nov; 85(22):11800-8. PubMed ID: 21880758
[TBL] [Abstract][Full Text] [Related]
8. Decanoyl-Arg-Val-Lys-Arg-Chloromethylketone: An Antiviral Compound That Acts against Flaviviruses through the Inhibition of Furin-Mediated prM Cleavage.
Imran M; Saleemi MK; Chen Z; Wang X; Zhou D; Li Y; Zhao Z; Zheng B; Li Q; Cao S; Ye J
Viruses; 2019 Oct; 11(11):. PubMed ID: 31683742
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of single-round infectious, chimeric dengue type 1 virus as an antigen for dengue functional antibody assays.
Yamanaka A; Suzuki R; Konishi E
Vaccine; 2014 Jul; 32(34):4289-95. PubMed ID: 24950360
[TBL] [Abstract][Full Text] [Related]
10. Alterations of pr-M cleavage and virus export in pr-M junction chimeric dengue viruses.
Keelapang P; Sriburi R; Supasa S; Panyadee N; Songjaeng A; Jairungsri A; Puttikhunt C; Kasinrerk W; Malasit P; Sittisombut N
J Virol; 2004 Mar; 78(5):2367-81. PubMed ID: 14963133
[TBL] [Abstract][Full Text] [Related]
11. Luteolin escape mutants of dengue virus map to prM and NS2B and reveal viral plasticity during maturation.
Peng M; Swarbrick CMD; Chan KW; Luo D; Zhang W; Lai X; Li G; Vasudevan SG
Antiviral Res; 2018 Jun; 154():87-96. PubMed ID: 29665375
[TBL] [Abstract][Full Text] [Related]
12. Characterization of dengue virus 2 growth in megakaryocyte-erythrocyte progenitor cells.
Clark KB; Hsiao HM; Bassit L; Crowe JE; Schinazi RF; Perng GC; Villinger F
Virology; 2016 Jun; 493():162-72. PubMed ID: 27058763
[TBL] [Abstract][Full Text] [Related]
13. Luteolin restricts dengue virus replication through inhibition of the proprotein convertase furin.
Peng M; Watanabe S; Chan KWK; He Q; Zhao Y; Zhang Z; Lai X; Luo D; Vasudevan SG; Li G
Antiviral Res; 2017 Jul; 143():176-185. PubMed ID: 28389141
[TBL] [Abstract][Full Text] [Related]
14. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization.
Nelson S; Jost CA; Xu Q; Ess J; Martin JE; Oliphant T; Whitehead SS; Durbin AP; Graham BS; Diamond MS; Pierson TC
PLoS Pathog; 2008 May; 4(5):e1000060. PubMed ID: 18464894
[TBL] [Abstract][Full Text] [Related]
15. The infectivity of prM-containing partially mature West Nile virus does not require the activity of cellular furin-like proteases.
Mukherjee S; Lin TY; Dowd KA; Manhart CJ; Pierson TC
J Virol; 2011 Nov; 85(22):12067-72. PubMed ID: 21880759
[TBL] [Abstract][Full Text] [Related]
16. Pseudo-infectious reporter virus particles for measuring antibody-mediated neutralization and enhancement of dengue virus infection.
Mukherjee S; Pierson TC; Dowd KA
Methods Mol Biol; 2014; 1138():75-97. PubMed ID: 24696332
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of chimeric DNA vaccines consisting of premembrane and envelope genes of Japanese encephalitis and dengue viruses as a strategy for reducing induction of dengue virus infection-enhancing antibody response.
Sjatha F; Kuwahara M; Sudiro TM; Kameoka M; Konishi E
Microbiol Immunol; 2014 Feb; 58(2):126-34. PubMed ID: 24372832
[TBL] [Abstract][Full Text] [Related]
18. Immature dengue virus: a veiled pathogen?
Rodenhuis-Zybert IA; van der Schaar HM; da Silva Voorham JM; van der Ende-Metselaar H; Lei HY; Wilschut J; Smit JM
PLoS Pathog; 2010 Jan; 6(1):e1000718. PubMed ID: 20062797
[TBL] [Abstract][Full Text] [Related]
19. Generation of Mature DENVs via Genetic Modification and Directed Evolution.
Tse LV; Meganck RM; Dong S; Adams LE; White LJ; Mallory ML; Jadi R; de Silva AM; Baric RS
mBio; 2022 Jun; 13(3):e0038622. PubMed ID: 35481749
[TBL] [Abstract][Full Text] [Related]
20. The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states.
Lee PD; Mukherjee S; Edeling MA; Dowd KA; Austin SK; Manhart CJ; Diamond MS; Fremont DH; Pierson TC
J Virol; 2013 Dec; 87(24):13729-40. PubMed ID: 24109224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
